MAPT and Alzheimer disease: Similarly, the partial reduction of VDAC1 expression in AD transgenic mice counteracted Tau‐related pathology by increasing mitochondrial fission and biogenesis, mitophagy, and synaptic functions (Vijayan and Reddy 2022; Vijayan et al. 2022).